{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:32:59Z","timestamp":1791923579946,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017949","name":"Health Commission of Shanxi Province","doi-asserted-by":"publisher","award":["2020SY19"],"award-info":[{"award-number":["2020SY19"]}],"id":[{"id":"10.13039\/100017949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151597","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:53:28Z","timestamp":1774972408000},"page":"151597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Functional characterization of triokinase\/FMN cyclase as a ferroptosis regulator and potential direct target of icaritin in hepatocellular carcinoma"],"prefix":"10.1016","volume":"358","author":[{"given":"Wenpei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151597_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl","key":"10.1016\/j.ijbiomac.2026.151597_bb0010","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151597_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.gastro.2025.03.047","article-title":"Advances in locoregional and systemic treatments for hepatocellular carcinoma","volume":"169","author":"Singal","year":"2025","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cytogfr.2024.08.006","article-title":"Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis","volume":"79","author":"Yu","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151597_bb0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","article-title":"Decoding ferroptosis for cancer therapy","volume":"25","author":"Wahida","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151597_bb0035","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.7150\/ijbs.96014","article-title":"Current progress of ferroptosis study in hepatocellular carcinoma","volume":"20","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151597_bb0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/HEP.0000000000000390","article-title":"Ferroptosis in hepatocellular carcinoma: from bench to bedside","volume":"80","author":"Tang","year":"2024","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151597_bb0045","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.7150\/ijbs.107195","article-title":"Regulated cell death in lenvatinib resistance of hepatocellular carcinoma: from molecular mechanisms to therapeutic strategies","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117769","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"182","author":"Tu","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116074","article-title":"From synergy to resistance: navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma","volume":"170","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12072-023-10593-y","article-title":"Targeting ferroptosis in hepatocellular carcinoma","volume":"18","author":"Mo","year":"2024","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151597_bb0065","first-page":"186","article-title":"Antineoplastic effects of icaritin: molecular mechanisms and applications","volume":"4","author":"Luo","year":"2025","journal-title":"Acta Mater. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1142\/S0192415X25500089","article-title":"Advances in pharmacological research on icaritin: a comprehensive review","volume":"53","author":"Guo","year":"2025","journal-title":"Am. J. Chin. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151597_bb0075","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1007\/s00204-020-02867-3","article-title":"Rapid intestinal glucuronidation and hepatic glucuronide recycling contributes significantly to the enterohepatic circulation of icaritin and its glucuronides in vivo","volume":"94","author":"Rong","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"15_suppl","key":"10.1016\/j.ijbiomac.2026.151597_bb0080","article-title":"A randomized, double-blinded, phase III study of icaritin versus huachansu in patients with advanced hepatocellular carcinoma","volume":"39","author":"Qin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216621","article-title":"Icaritin with autophagy\/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1\/Parkin-mediated mitophagy in hepatocellular carcinoma","volume":"587","author":"Luo","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151597_bb0090","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","article-title":"Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12885-021-08043-9","article-title":"Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109124","article-title":"Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma","volume":"325","author":"Bailly","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151597_bb0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/eji.202048905","article-title":"Icaritin inhibits PD-L1 expression by targeting protein I\u03baB kinase \u03b1","volume":"51","author":"Mo","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151597_bb0110","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/biomedicines12081917","article-title":"Icaritin exerts anti-cancer effects through modulating pyroptosis and immune activities in hepatocellular carcinoma","volume":"12","author":"Jiao","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.609295","article-title":"Icaritin induces anti-tumor immune responses in hepatocellular carcinoma by inhibiting splenic myeloid-derived suppressor cell generation","volume":"12","author":"Tao","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12885-019-5471-1","article-title":"First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers","volume":"19","author":"Fan","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156870","article-title":"Icaritin induces paraptosis in hepatocellular carcinoma cells by targeting BHLHE40 via endoplasmic reticulum stress and mitochondrial dysfunction","volume":"143","author":"Wei","year":"2025","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151597_bb0130","first-page":"1295","article-title":"Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG\/FABP4\/GPX4 pathway","volume":"49","author":"Li","year":"2024","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/13880209.2019.1628073","article-title":"Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells","volume":"57","author":"Wang","year":"2019","journal-title":"Pharm. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151597_bb0140","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1111\/cas.14641","article-title":"Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: immunodynamic biomarkers and overall survival","volume":"111","author":"Qin","year":"2020","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2020.12.015","article-title":"The evolving landscape of noncanonical functions of metabolic enzymes in cancer and other pathologies","volume":"33","author":"Xu","year":"2021","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151597_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/CS20220661","article-title":"Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization","volume":"137","author":"Xu","year":"2023","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41467-024-55785-8","article-title":"S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151597_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119639","article-title":"Proline and dihydroorotate dehydrogenase promote a hyper-proliferative state and dampen ferroptosis in cancer cells by rewiring mitochondrial redox metabolism","volume":"1871","author":"Mailloux","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151597_bb0165","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.cmet.2021.09.010","article-title":"Molecular aspects of fructose metabolism and metabolic disease","volume":"33","author":"Herman","year":"2021","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151597_bb0170","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/1873-3468.14309","article-title":"The TKFC Ala185Thr variant, reported as \u2018null\u2019 for fructose metabolism, is fully active as triokinase","volume":"596","author":"Ribeiro","year":"2022","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151597_bb0175","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/nu15071778","article-title":"Recent progress on fructose metabolism-Chrebp, fructolysis, and polyol pathway","volume":"15","author":"Iizuka","year":"2023","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.151597_bb0180","doi-asserted-by":"crossref","first-page":"10620","DOI":"10.1074\/jbc.M113.525626","article-title":"Bifunctional homodimeric triokinase\/FMN cyclase: contribution of protein domains to the activities of the human enzyme and molecular dynamics simulation of domain movements","volume":"289","author":"Rodrigues","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151597_bb0185","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3390\/nu13051678","article-title":"Effects of three-month administration of high-saturated fat diet and high-polyunsaturated fat diets with different linoleic acid to \u03b1-linolenic acid ratio on the mouse liver proteome","volume":"13","author":"Liput","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101243","article-title":"Non-canonical NRF2 activation promotes a pro-diabetic shift in hepatic glucose metabolism","volume":"51","author":"Liu","year":"2021","journal-title":"Mol. Metab."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151597_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.102012","article-title":"Identification of differentially expressed miRNAs and key genes involved in the progression of alcoholic fatty liver disease using rat models","volume":"46","author":"Zhang","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0200","article-title":"LINC317.5 as a novel biomarker for hypertriglyceridemia in normal glucose metabolism","volume":"10","author":"Yang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106957","article-title":"Integrative computational modeling to unravel novel potential biomarkers in hepatocellular carcinoma","volume":"159","author":"Walakira","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151597_bb0210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncb3338","article-title":"A splicing switch from ketohexokinase-C to ketohexokinase-a drives hepatocellular carcinoma formation","volume":"18","author":"Li","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.151597_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm7985","article-title":"Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging","volume":"8","author":"Tee","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151597_bb0220","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1038\/s41467-025-64572-y","article-title":"FAD synthase confers ferroptosis resistance and restrains CD8+ T cell recruitment in hepatocellular carcinoma","volume":"16","author":"Chao","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151597_bb0225","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1021\/acsami.4c13433","article-title":"Mitochondria-targeted icaritin nanoparticles induce immunogenic cell death in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0230","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eng.2025.08.019","article-title":"Icaritin improves the hematopoiesis-supportive function of MSCs via a PRDX1\u2013MAPK axis after chemotherapy","volume":"54","author":"Pengli","year":"2025","journal-title":"Engineering"},{"key":"10.1016\/j.ijbiomac.2026.151597_bb0235","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2147\/IJGM.S341502","article-title":"Pan-cancer analyses confirmed the ferroptosis-related gene SLC7A11 as a prognostic biomarker for cancer","volume":"15","author":"Lin","year":"2022","journal-title":"Int. J. Gen. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151597_bb0240","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/liv.15839","article-title":"Impact of ACSL4 on the prognosis of hepatocellular carcinoma: association with cancer-associated fibroblasts and the tumour immune microenvironment","volume":"44","author":"Toshida","year":"2024","journal-title":"Liver Int."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026015230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026015230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:22:05Z","timestamp":1776122525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026015230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S0141813026015230"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151597","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of triokinase\/FMN cyclase as a ferroptosis regulator and potential direct target of icaritin in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"151597"}}